Key statistics
On Friday, Eton Pharmaceuticals Inc (ETON:NMQ) closed at 5.42, -9.97% below its 52-week high of 6.02, set on Sep 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.89 |
---|---|
High | 5.91 |
Low | 5.35 |
Bid | 3.94 |
Offer | 5.90 |
Previous close | 5.90 |
Average volume | 188.54k |
---|---|
Shares outstanding | 25.84m |
Free float | 24.44m |
P/E (TTM) | -- |
Market cap | 140.03m USD |
EPS (TTM) | -0.2596 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
- Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
- Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
- Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
- Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
- Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
- Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
- Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
- Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
- Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
More ▼